Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Stefania Bello"'
Autor:
Filippo Genuario, Giuseppe Santoro, Michele Giliberti, Stefania Bello, Elvira Zazzera, Donato Impedovo
Publikováno v:
Information, Vol 15, Iss 11, p 741 (2024)
The number of connected IoT devices is increasing significantly due to their many benefits, including automation, improved efficiency and quality of life, and reducing waste. However, these devices have several vulnerabilities that have led to the ra
Externí odkaz:
https://doaj.org/article/e33e83deef3043fa8b14d489612cf99c
Publikováno v:
Gynecologic Oncology Reports, Vol 56, Iss , Pp 101524- (2024)
Background: Synchronous endometrial and ovarian carcinomas represent up to 10% of all endometrial and ovarian tumors. These are diagnostically challenging cases to determine if they represent dual primary tumors or related metastatic tumors. Case: A
Externí odkaz:
https://doaj.org/article/2ddaaff38f66436889db9cfdb27b4f0b
Autor:
Dana M. Roque, Eric R. Siegel, Natalia Buza, Stefania Bellone, Gloria S. Huang, Gary Altwerger, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E. Schwartz, Gautam G. Rao, Elena Ratner, Alessandro D. Santin
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-7 (2024)
Abstract Background Ixabepilone may retain activity in paclitaxel-resistant disease. We previously reported improved response rates (ORR), progression-free (PFS), and overall survival (OS) conferred by ixabepilone+bevacizumab (IXA + BEV) compared to
Externí odkaz:
https://doaj.org/article/f49671ab396045a1849b78083c690bd0
Autor:
Stefania Bello, Germano Guglielmi
Publikováno v:
European State Aid Law Quarterly. 19:440-451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::105bd88a60def0251748e58568c7932e
https://doi.org/10.21552/estal/2020/4/6
https://doi.org/10.21552/estal/2020/4/6
Autor:
Germano Guglielmi, Stefania Bello
Publikováno v:
European State Aid Law Quarterly. 19:297-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5a6ae1e02aaa0b1b6c31caa0f5cba59
https://doi.org/10.21552/estal/2020/3/7
https://doi.org/10.21552/estal/2020/3/7
Autor:
Tobias Max Philipp Hartwich, Miranda Mansolf, Cem Demirkiran, Michelle Greenman, Stefania Bellone, Blair McNamara, Shuvro P. Nandi, Ludmil B. Alexandrov, Yang Yang‐Hartwich, Silvia Coma, Jonathan Pachter, Alessandro D. Santin
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Background High‐grade endometrial cancers (EAC) are aggressive tumors with a high risk of progression after treatment. As EAC may harbor mutations in the RAS/MAPK pathways, we evaluated the preclinical in vitro and in vivo efficacy of avut
Externí odkaz:
https://doaj.org/article/c903116f7e7848cf816112aa15bc9253
Autor:
Michelle Greenman, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101459- (2024)
Background: Treatment of recurrent platinum-resistant high grade serous ovarian cancer (HGSOC) remains a challenge. Novel treatment options for recurrent disease are an unmet need. Case: A 69-year-old with recurrent, metastatic, platinum-resistant HG
Externí odkaz:
https://doaj.org/article/05c903bfcc1a4000b08786ea06630865
Publikováno v:
Gynecologic Oncology Reports, Vol 51, Iss , Pp 101324- (2024)
Up to 30 % of COVID-infected patients may develop post-acute sequelae of COVID-19 (PASC), also known as Long COVID (LC), a syndrome characterized by a variety of debilitating symptoms lasting for more than 3 months after the acute infection. While th
Externí odkaz:
https://doaj.org/article/b9c2e6db927c46d0abad4bbc55e50e26
Publikováno v:
Gynecologic Oncology Reports, Vol 50, Iss , Pp 101301- (2023)
Post-acute sequelae of COVID-19 (PASC), also known as Long-Covid (LC), may affect 10–30 % of COVID-infected patients, and is characterized by a variety of debilitating symptoms lasting over 3 months after the acute infection, including but not limi
Externí odkaz:
https://doaj.org/article/1f5b58ce2ece47c78b1217bacc38bd76
Autor:
Blair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp 101219- (2023)
Background: Treatment of uterine serous carcinoma (USC) is challenging; effective treatment options for metastatic and recurrent disease are needed. Case: A 68-year-old woman with recurrent, metastatic, USC overexpressing HER2/neu experienced durable
Externí odkaz:
https://doaj.org/article/65f35d1815de4ce1953b17e0506522e9